Despite the recent market downturn, Aave (AAVE) has become one of the best performing altcoins.
The price spike, however, has caused some investors to take profits, with Aave’s founder and CEO, Stan Kulechov, among the sellers.
Stani Kulechov(@StaniKulechov), the founder of #Aave is selling $AAVE!
Since Feb 26, Stani Kulechov has sold 55,596 $AAVE($6.67M) and currently holds 243,900 $AAVE($32.7M).
Address:
0xe705b1D26B85c9F9f91A3690079D336295F14F08 pic.twitter.com/0D95c6L5xJ— Lookonchain (@lookonchain) September 5, 2024
According to blockchain analytics company LookOnChain, since February, Kulechev has sold 55,596 AAVE tokens worth $6.67 million, leaving with 243,900 coins worth over $32 million.
Investors holding AAVE over the past three to six months have recorded unrealized gains of 27% and 26%, respectively, according to market-to-value ratio (MVRV) data, suggesting the token may be overvalued. This has increased the potential for greater profit-taking.
On the charts, AAVE has encountered resistance near $140, where intermediate-term holders, including Kulechev, have likely taken profits. The $118 level has acted as key support since late August, with potential buying opportunities around $118 and $109 if selling pressure continues at $140.
However, AAVE is considered a promising investment, backed by growing interest in DeFi and support from major crypto venture capitalists.
Fartcoin (FARTCOIN) has gone down by 17.3% in the past 24 hours and currently sits at $1.14. As the token approaches $1, one trader favors a bullish Fartcoin price prediction. DevKhabib, a pseudonymous trader whose X account is followed by nearly 46,000 users, says that he expects a big bounce off the $1 support after […]
Amid current market volatility, blockchain analytics firm Santiment has reported a notable rise in whale activity targeting a select group of altcoins.
Binance has officially announced the launch of PlaysOut (PLAY), a new token debuting on Binance Alpha, with trading scheduled to begin on July 31, 2025, at 08:00 UTC.
The Cboe BZX Exchange has submitted a filing with the U.S. Securities and Exchange Commission (SEC) seeking approval for a new exchange-traded fund (ETF) that would track Injective’s native token (INJ).